Khurana RK - Search Results

1

Comparing Progesterone Primed Ovarian Stimulation (PPOS) to GnRH Antagonist Protocol in Oocyte Donation Cycles.

Khurana RK, Rao V, Nayak C, Pranesh GT, Rao KA. Khurana RK, et al. J Hum Reprod Sci. 2022 Jul-Sep;15(3):278-283. doi: 10.4103/jhrs.jhrs_85_22. Epub 2022 Sep 30. J Hum Reprod Sci. 2022. PMID: 36341015 Free PMC article.

2

Effects of Oral Leak Size on Valsalva Responses.

Khurana RK, Mittal D. Khurana RK, et al. J Community Hosp Intern Med Perspect. 2022 Jul 4;12(4):114-120. doi: 10.55729/2000-9666.1080. eCollection 2022. J Community Hosp Intern Med Perspect. 2022. PMID: 36262891 Free PMC article.

3

Engineered Site-specific Vesicular Systems for Colonic Delivery: Trends and Implications.

Goel H, Razdan K, Singla R, Talegaonkar S, Khurana RK, Tiwary AK, Sinha VR, Singh KK. Goel H, et al. Among authors: khurana rk. Curr Pharm Des. 2020;26(42):5441-5455. doi: 10.2174/1381612826666200813132301. Curr Pharm Des. 2020. PMID: 32787754 Review.

4

Involuntary emotional expression disorder in postural tachycardia syndrome.

Khurana RK. Khurana RK. Auton Neurosci. 2020 Jul;226:102660. doi: 10.1016/j.autneu.2020.102660. Epub 2020 Mar 19. Auton Neurosci. 2020. PMID: 32298990

5

Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting.

Choudhury H, Gorain B, Pandey M, Khurana RK, Kesharwani P. Choudhury H, et al. Among authors: khurana rk. Int J Pharm. 2019 Jun 30;565:509-522. doi: 10.1016/j.ijpharm.2019.05.042. Epub 2019 May 15. Int J Pharm. 2019. PMID: 31102804 Review.

6

Aspartic acid tagged carbon nanotubols as a tool to deliver docetaxel to breast cancer cells: Reduced hemotoxicity with improved cytotoxicity.

Thotakura N, Sharma S, Khurana RK, Babu PV, Chitkara D, Kumar V, Singh B, Raza K. Thotakura N, et al. Among authors: khurana rk. Toxicol In Vitro. 2019 Sep;59:126-134. doi: 10.1016/j.tiv.2019.04.012. Epub 2019 Apr 13. Toxicol In Vitro. 2019. PMID: 30986424

7

QbD-Based Development of Cationic Self-nanoemulsifying Drug Delivery Systems of Paclitaxel with Improved Biopharmaceutical Attributes.

Beg S, Kaur R, Khurana RK, Rana V, Sharma T, Singh B. Beg S, et al. Among authors: khurana rk. AAPS PharmSciTech. 2019 Feb 21;20(3):118. doi: 10.1208/s12249-019-1319-x. AAPS PharmSciTech. 2019. PMID: 30790136

8

Potential of Natural Biomaterials in Nano-scale Drug Delivery.

Houacine C, Yousaf SS, Khan I, Khurana RK, Singh KK. Houacine C, et al. Among authors: khurana rk. Curr Pharm Des. 2018;24(43):5188-5206. doi: 10.2174/1381612825666190118153057. Curr Pharm Des. 2018. PMID: 30657035 Review.

9

Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.

Khurana RK, Kumar R, Gaspar BL, Welsby G, Welsby P, Kesharwani P, Katare OP, Singh KK, Singh B. Khurana RK, et al. Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:645-658. doi: 10.1016/j.msec.2018.05.010. Epub 2018 May 4. Mater Sci Eng C Mater Biol Appl. 2018. PMID: 30033299

10

Syncope and Headache.

Khurana RK. Khurana RK. Curr Pain Headache Rep. 2018 Jun 15;22(8):54. doi: 10.1007/s11916-018-0706-4. Curr Pain Headache Rep. 2018. PMID: 29904895 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page